Evidence map›Paper›PMID 42663467›Full record

ArticlemSphere2026

Minimal organism JCVI-syn3.0, an engineered derivative of

Arcady R Mushegian, Phillip K Yamamoto, Naoki Torikai, Kazuharu Arakawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arcady R MushegianDivision of Molecular and Cellular Biosciences, National Science Foundation, Alexandria, Virginia, USA.ORCID 0000-0002-6809-9225
Phillip K YamamotoInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
Naoki TorikaiInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
Kazuharu ArakawaInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.ORCID 0000-0002-2893-4919

Funding

National Science Foundation intramural IRD programYamagata Prefectural Government and Tsuruoka City n/a
6 · The paper itself

Abstract

In 2016, researchers at the J. Craig Venter Institute produced JCVI-Syn3.0, a derivative of

Indexed as

Bacterial ProteinsMembrane Transport ProteinsMycoplasma mycoidesGenetic EngineeringGenome, BacterialModels, MolecularBacterial ProteinsMembrane Transport Proteinsbacterial immunityCas4JCVI-Syn3.0minimal genomeMycoplasma mycoides

Identifiers

PMID42663467
PMCPMC13621843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.